Mutations or deficiencies in the MMR system, particularly involving Msh2, lead to a condition known as microsatellite instability (MSI). MSI is characterized by a high frequency of mutations within microsatellite regions of the genome, which are repetitive DNA sequences. This instability can drive oncogenesis, as the accumulation of genetic errors can lead to the activation of oncogenes or inactivation of tumor suppressor genes.
